3rd Quarter - Amendment

QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED

Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2025 $360,000 Replaced
3rd Quarter - Amendment (this page) Jan 20, 2026 $310,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2761 (119th), H.R. 5269 (119th), H.R. 5571 (119th), S. 1816 (119th), H.R. 3514 (119th)

Medicare/Medicaid MMM

P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6363 (119th)

Budget/Appropriations BUD

Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.